You are here: Industry Insights > Vaccine Candidate

News List

Medicago and GSK Announce Positive Phase 3 Efficacy and Safety Results for Adjuvanted Plant-Based COVID-19 Vaccine Candidate AmericanPharmaceuticalReview
December 09, 2021
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline announced positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago's plant-based COVID-19 vaccine candidate in...
Johnson & Johnson Announces that Janssen’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies drugs.com
September 24, 2020
Janssen’s lead SARS-CoV-2 investigational vaccine candidate, Ad26.COV2.S, prevented severe clinical disease in Syrian golden hamsters, upon challenge with SARS-CoV-2, the virus that causes COVID-19 in people.
COVID-19 vaccine candidate produced from insect cells to enter human trials chinadaily
August 26, 2020
China has approved human trials for a new COVID-19 vaccine candidate, which was produced by the use of insect cells.
Italy researchers claim vaccine neutralises coronavirus in human cells pharmaceutical-technology
May 06, 2020
Scientists at Lazzaro Spallanzani National Institute for Infectious Diseases in Italy have claimed that a vaccine candidate could neutralise coronavirus within human cells.
Germany to begin first clinical trial of COVID-19 vaccine candidate europeanpharmaceuticalreview
April 24, 2020
A Phase I/II clinical trial for BioNTech’s BNT162 vaccine programme to prevent COVID-19 infection has been granted approval in Germany.
DBT and BIRAC recommend 16 proposals for funding support towards COVID-19 Research Consortium expresspharma
April 21, 2020
In the wake of the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) inviting applications on COVID-19 Research Consortium, around 500 applications were received from academia and industry.